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SUMMARY.-Early " prophylactic " oophorectomy and adrenalectomy has
been performed on 12 patients with carcinoma of the breast. The patients
selected were considered to have a very bad prognosis on account of axillary
node involvement associated with internal mammary chain deposits (9
patients), supraclavicular nodes (2 patients) and a parasternal mass (1 patient).
Five patients had evidence of spread beyond the primary lymph drainage area
(axillary and internal mammary nodes), and all had died within 4 years. In 7
patients the disease was confined to the primary lymph drainage area and 4
lived for more than 10 years, 3 being alive and well at 11 to 12 years. This is a
higher proportion than in a control series but does not quite reach the level of
statistical significance. In the 7 patients with disease confined to the axillary
and internal mammary nodes prognosis was not apparently related to malig-
nancy determined histologically, but did have an association with the extent
of invasion of the axillary nodes. Urinary oestrogen estimations performed in
4 patients did not give any evidence that outcome was related to persistence of
oestrogen production. Details of the patients' management and replacement
therapy are given and from prolonged personal follow-up of these patients it is
concluded that women who have undergone oophorectomy and adrenalectomy
are able to lead full and active lives.
IN 1960 one of us (DHP) published an interim report on the results of
"prophylactic " oophorectomy and adrenalectomy performed between 1954 and
1959 on 11 patients with carcinoma of the breast. The indication for operation
was not the usual one ofgeneraliseddisease, butthepresence ofevidence suggesting
a very poor prognosis in the absence ofgeneralised disease. The operations were
therefore " prophylactic " inthe sense that it washopedthattheymightfavourably
influence the poor prognosis. More than ten years have now passed since the last
adrenalectomy wasperformed andtheresults to date (December 1969) are analysed
in this report. In addition details of the long term management of the patients,
an assessment of the effects of the operations on the patients' well being, and
results of urinary oestrogen estimations in 4 of the patients are described. In
Table I the details of the patients are given, numbered as in the previous report
(Patey, 1960) with the addition of case 12, that was omitted from the previous
account.
Selection ofpatients
For inclusion in this study two criteria had to be fulfilled: firstly that theOOPHORECTOMY AND ADRENALECTOMY IN BREAST CANCER
prognosis was bad, and secondly that thepatient was able to understand the nature
and purpose ofthe operation. In all cases the husbands were also interviewed and
the situation explained. This was regarded as a pilot study, the numbers were
deliberately kept small, and no further operations ofthistype have been performed
since October 1959.
In 9 patients evidence ofa bad prognosis was the histological finding ofaxillary
and internal mammary lymph node involvement in specimens from the primary
operation. In all except one of these the internal mammary involvement was
determined by biopsy of the second intercostal space. Handley (1969, personal
communication) has shown that such double lymph node involvement is associated
with a very bad prognosis. In 2 ofthese 9 cases other metastases were demonstra-
ted radiologically (in case 5 in a vertebra and in case 9 an apparently solitary lung
deposit). In 2 patients evidence of further spread was found in the course of
hormonal surgery.
In the other 3 patients (numbers 1, 2, and 4) the axillary lymph nodes were
extensively invaded; in addition in cases 1 and 4 there was evidence of supra-
clavicular node involvement-now generally regarded as a sign that the disease
has reached an incurable stage, and in case 2 a parasternal mass of carcinoma and
a deposit in the sternum.
In 10 ofthe patients hormonal surgery was performed shortly after the primary
operation. In the other 2 (1 and 9) it was performed 4 years after the
primary operation because ofthe development ofrecurrences. In all cases the pri-
mary operation was a " modified radical mastectomy " with removal ofthe breast
and axillary nodes in continuity preserving the pectoralis major (Patey and Dyson,
1948). In case 9 this operation was extended to include removal of the internal
mammary chain on the same side (Handley, Patey and Hand, 1956).
Post-operative treatment andfollow-up
The programme of steroid cover for adrenalectomy has been described else-
where (Nabarro, 1960). Replacement therapy given subsequently was cortisone
acetate 12-5 mg. three times daily, and fludrocortisone 0-1 mg. daily. Initially
the patients were seen at monthly intervals, later every 3-4 months. Weight and
blood pressure were checked, and the electrolytes and blood urea estimated. The
patients were advised to increase the dose of cortisone if they developed an
intercurrent illness and were supplied with bottles of injectable cortisone acetate
to facilitate parenteral therapy if they had any illness associated with vomiting.
Replacement therapy presented little problem, although patient number 7 had
to be admitted to hospital on one occasion with acute adrenal insufficiency follow-
ing acute gastro-enteritis. Patient number 11 developed an ulcerating local
recurrence that spread relentlessly 4 years after operation. She was started
shortly before she died on an androgenic steroid, and apparently misunderstood
the instructions given to her, because she stopped her replacement therapy. Her
death at home shortly after must be attributed at least in part to adrenal insuffi-
ciency. This is a serious consideration in the performance of an operation in
which vital glands are being removed, and every effort was made to emphasise to
the patients the importance of continuing replacement therapy. We believe the
failure in this case may be partly attributable to the patient's very poor general
condition at the time.
2
17D. H. PATEY AND J. D). N. NABARRO
RESULTS
Nine patients have died of the disease, 3 are alive and well. Six of the 9
patients who died of the disease did so comparatively soon after the hormonal
surgery (cases 1, 2, 4, 5, 6, 9). One patient died at 6 years, and 2 after remaining
well for 9 years developed recurrences and died of the disease, one at 91 (case 3).
and the other at 11 years (case 12).
Analysing the results further, all 5 patients who at the time ofhormonal surgery
had deposits of growth outside the primary lymph drainage area, i.e. the axillary
and internal mammary lymph nodes, died of the disease within a short time
(cases 1, 2, 4, 5, 9). Ofthe remaining 7 patients in whom the disease was confined
to the primary lymph drainage area, 4 have died ofthe disease, and 3 are alive and
well. Of the 4 who have died, 1 did so approximately a year after hormonal
surgery (case 6), 1 at 6 years (case 11), 1 at 91 years (case 3), and 1 at 11 years
(case 12). Eleven to 12 years have passed since the 3 patients still alive (cases 7,
8 and 10) underwent hormonal surgery.
In 4 of the patients in this series, the urinary oestrone, oestradiol-17P and
oestriol were measured on a number of occasions by IDr. Bulbrook and Dr.
Greenwood at the laboratories of the Imperial Cancer Research Fund, using the
method described by Brown, Bulbrook and Greenwood (1957). In patient 1,
three estimations were made after operation; in 2 samples no oestrogen was found,
and in one, 1 1 ,ug. in 24 hours. In patient 2, 17 24-hour urine collections were
examined at approximately monthly intervals, from 6 to 28 months afteroperation.
In 14, no oestrogen could be detected; in the remaining 3 samples the total
oestrogens were 2-4, 3.3, and 3-8 jag. per 24 hours. In patient number 3, who
survived 9 years, 17 urine collections were studied from 6 months to 28 months
after operation, again at approximately monthly intervals; in 12 no oestrogen
could be detected, and in the remainder the levels were 1-6, 1-7, 3-2, 4-7 and 6-2 ,tg.
per 24 hours. In patient number 4, more detailed studies were made; the urinary
oestrogen levels at the time of oophorectomy were 8-12 ,ug. per 24 hours, and fell
to zero after 5 days. Adrenalectomy was performed 2 weeks later, and traces of
oestrogen could be detected subsequently-2 ,tg. per 24 hours. Five months
after operation a single sample contained 1 pg. per 24 hours. In 3 samples,
collected subsequently, the last 1 month before the patient died, no oestrogen
could be found.
DISCUSSION
In the 1960 interim report it was concluded that, as 6 patients had already
either died of the disease or, if alive, had developed recurrence, though " a longer
follow-up will be needed before final conclusions are reached . .. the interim
conclusion seems justified that early oophorectomy and adrenalectomy are
unlikely to offer a significant contribution to the problem of carcinoma of the
breast ". The longer follow-up herewith reported would confirm this conclusion
for the 5 cases in which the growth had spread beyond the primary lymph drainage
area. The question, however, of whether the hormonal surgery influenced the
course ofthe disease in the 7 cases in which the growth was confined to the primary
lymph drainage area requires further consideration.
For comparison Mr. R. S. Handley has kindly furnished us with the up-to-date
10-year results in his unique series of 300 cases in which biopsy of the internal
mammary chain was performed as a routine at the time of the primary treatment
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for carcinoma ofthe breast. There were 79 patients in whom there washistological
involvement of both the axillary and internal mammary lymph nodes. Of these,
71 have died of the disease, 3 are alive with disease, and 5 are alive and well after
10 or more years without evidence of recurrence (6-33%). In the present series,
3 of 7 patients are alive and well at 10 or more years without evidence ofrecurrence
(42.8%). The standard error of the difference between the proportions is 18.9%.
The observed difference is 35 47%0, 1-88 times the standard error, and therefore not
quite significant at 95oo level of confidence.
These 7 cases can be further analysed on the degree of axillary lymph node
involvement, and on histological grading, which was kindly performed by Dr.
John Arthur without knowledge of the clinical features. In 3 patients there
was extensive axillary node involvement (cases 3, 6, and 11). All have died ofthe
disease although one survived 92 years (case 3). In the other 4 patients axillary
node involvement was limited to 3 nodes or less, 3 of these patients are alive and
well at 11 to 12 years (case 7, 8 and 10) and the fourth died at 11 years (case 12).
There was no obvious relation between histological grading and outcome (see
Table I), best shown by the grades of the 3 surviving patients (high, intermediate
and low).
The results of hormonal surgery bore no relation to the results of urinary
oestrogen estimations. Of the 4 patients studied, 3 did not derive any benefit
from the operation (cases, 1, 2, and 4), whereas one survived 92 years (case 3).
Post-operative urinary oestrogen levels were low in all the patients studied, the
highest being found in the patient with the longest survival. It seems unlikely
that poor response to operation is the result of persisting oestrogen secretion.
The 5 women who survived for prolonged periods without recurrence appeared
to have full and active lives. This certainly applied to patients 3 and 12, who
died 9 and 11 years after operation. The terminal stages were short about I
month in one and 6 in the other. The 3 patients still alive are also able to carry
out their usual duties as housewives, althotugh patient number 10 had had to have
a big toe amputated for a melanoma, number 8 feels a little unsure of her back
following the adrenalectomy incisions, and number 7, an anxious individual,
states that she has not felt the same since the operation, although she is generally
very active.
In assessing the quality oflife in these patients, the effects ofbilateral oophorec-
tomy on sex function have to be considered, but many ofthe patients were near, or
past the menopause when the operations were performed. Of the younger ones,
numbers 1 and 7 led active sex lives after operation. In patient 4, survival was
brief, and no information on this point was obtained. Of the older patients
with prolonged survival, no information is available on patient 3. Patient 8
reported that her sex life had not been altered by the operation, but that it had
never been very active. Patient 10 has found that libido is reduced, and patient
12 was a widow.
It is not possible to derive any definite conclusions from this limited pilot
study. The results suggest that early oophorectomy and adrenalectomy may
improve the expectation of life in women who have carcinoma of the breast with
spread confined to the axillary and internal mammary lymph nodes. However,
the improvement did not reach the level of statistical significance. Ifthe disease
has spread beyond the primary lymphatic drainage area, hormonal surgery in
absence ofsymptoms cannot be recommended. It can also be affirmedthatwomen
20OOPHORECTOMY AND ADRENALECTOMY IN BREAST CANCER 21
who have undergone oophorectomy and adrenalectomy are able to lead full and
active lives.
We wish to thank Mr. R. S. Handley for allowing us to include his results as
our " control " series, IDr. John Arthur for his histological assessments and Dr.
Bulbrook and Dr. Greenwood for performing the oestrogen assays and allowing
us to include them.
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